期刊文献+

弓形虫pc-DNA3-ROP2核酸疫苗的研制 被引量:4

Studies of pc-DNA3-ROP2 nucleic acid vaccine of Toxoplasma gondii
下载PDF
导出
摘要 目的研究廉价有效的抗弓形虫核酸疫苗,以用于人类和畜类弓形虫病的防治。方法收集、纯化RH株弓形虫速殖子,提取基因组DNA;根据ROP2基因序列,设计合成ROP2基因引物,应用PCR、酶切、连接、测序等技术,扩增ROP2基因片段,克隆于真核表达载体pc-DNA3质粒中,制备抗弓形虫pc-DNA3-ROP2核酸疫苗。应用该疫苗免疫小鼠,通过ELISA检测血清抗体,Western blot鉴定该疫苗的免疫原性;应用RH株弓形虫进行动物攻击实验,评价其安全性及免疫保护性。结果以弓形虫基因组DNA为模板,PCR扩增出1.7 kb ROP2基因片段,克隆于pc-DNA3质粒中,成功构建了pc-DNA3-ROP2重组质粒。测序结果显示,重组质粒包含了ROP2蛋白基因读码框内的完整序列,能完整表达ROP2的抗原蛋白。应用该疫苗免疫小鼠,能诱导产生强烈的细胞、体液免疫反应,使实验组小鼠攻虫感染后的存活时间明显延长,攻虫感染192 h后的存活率为77.8%,空质粒及PBS对照组存活率为0,差异有统计学意义(P<0.001);实验全程免疫小鼠未发生毒性及异常反应。结论该核酸疫苗具有很强的免疫原性,安全可靠,能诱导小鼠产生良好的免疫保护作用,具有很好的开发应用价值。 Objective To study an cheap and effective nucleic acid vaccine for control of Toxoplasmosis in human and animals. Methods Tachyzoites of Toxoplasma gondii RH strain were collected and depurated to obtain genome. Primers were designed and synthesized and ROP2 gene was amplified, then recombined into an eukaryotic expression vector of pc-DNA3, pc-DNA3-ROP2 was then constructed, The insert was identified by PCR amplification, enzyme digestion, conjunction and sequence analysis. Mice were immunized with this pc-DNA3-ROP2 nucleic acid vaccine. Immunogenicity of the vaccine was evaluated through detecting immunity indexes. Challenge experiment with T. gondii RH strain was conducted. The safety and protective effect of this vaccine was appraised, Results The specific gene fragment of ROP2 about 1.7 kb in length was amplified, The gene fragment cloned into pc-DNA3 was correct, Eukaryotic expression plasmid contained ROP2 gene fragment was successfully constructed. ROP2 nucleic acid vaccine could induce strong cellular and humoral immune response. The titer of antibodies in serum was high after inoculating. The antibody could recognize ROP2 protein antigen expressed in vitro, The death and survival time of mice in experiment was clearly delayed and prolonged compared with that of control group, The difference was statically significant(P〈0.01). The harmfulness of this vaccine inoculated to mice was not observed during the experiment. Conclusion The recombinant ROP2 nucleic acid vaccine is safe, its immunogenicity is potent. It could produce good immunoprotection and possesses significant value for development and application.
出处 《中国病原生物学杂志》 CSCD 2008年第5期374-378,共5页 Journal of Pathogen Biology
基金 山东省自然科学基金项目(No.022130133)
关键词 刚地弓形虫 棒状体蛋白2(ROP2) 基因重组 核酸疫苗 免疫保护作用 Toxoplasma gondii rhoptry protein (ROP2) gene recombinant nucleic acid vaccine immunoprotection
  • 引文网络
  • 相关文献

参考文献19

  • 1Remington JS,Mcleod R,Desmonts G, et al. Toxoplasmosis. In: Remington JS, Klein JO, editors. Infections diseases of the fetus and newborn infant[M]. 4th ed Philadelphia. WBSaunders,1995. 140-267.
  • 2崔君兆.对我国人群弓形虫感染的初步评估[J].中华预防医学杂志,1991,25:56-57.
  • 3Grant IH, Gold WM, Rosenblum M, et al. Toxoplasma gondii serology in HIV infected patients: the development of central nervous system Toxoplasmosis in AIDS[J]. AIDS, 1990,4:519-521.
  • 4Beckers CJ, Dubremetz JF, Mercereau-Puijalon O, et al. The Tozoplasma gondii rhoptry protein ROP2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed to the host cell cytoplasm [J]. Cell Biol,1994,127:947-961.
  • 5郭虹,陈观今,郑焕钦,周永安,吕芳丽.弓形虫ROP1基因真核表达重组质粒免疫小鼠后的免疫应答[J].中国寄生虫学与寄生虫病杂志,1999,17(6):334-337. 被引量:17
  • 6吴昆,陈晓光,李华,支国舟.弓形虫ROP2基因的体外扩增及真核表达重组质粒的构建[J].第一军医大学学报,2002,22(7):620-623. 被引量:10
  • 7Gelder PV, Bosman F, Meuter FD,et al. Serodiagnosis of toxoplasmosis by using a recombinant form of the 54-kilodalton rhoptry antigen expressed in Escherichia coli[J]. J Clin Mierobiol,1993,31(1):9-15.
  • 8Leyva R, Herion P, Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii[J]. Parasitol Res, 2001,87(1) :70-79.
  • 9Fachado A, Rodriguez A, Angel SO,et al. Protective effect of a naked DNA vaccine cocktail against Lethal toxoplasmosis in mice [J]. Vaccine, 2003,21:1327-1335.
  • 10王世海,熊美华,王秀珍,刘露霞.弓形虫速殖子细胞质、细胞膜、排泄-分泌抗原蛋白分子测定及特异性免疫反应的试验分析[J].中国寄生虫病防治杂志,2003,16(3):144-146. 被引量:9

二级参考文献15

共引文献28

同被引文献48

引证文献4

二级引证文献23

;
使用帮助 返回顶部